About 5% to 10% of all cancers are caused by inherited gene mutations passed down through families. The rest develop from random DNA changes that accumulate over a lifetime. While any cancer can occasionally cluster in families, certain cancers have well-established genetic links, with specific gene mutations that dramatically increase a person’s lifetime risk. The most common hereditary cancers involve the breast, ovaries, colon, uterus, prostate, and pancreas.
How Hereditary Cancer Differs From Other Cancer
Every cancer is caused by DNA mutations, but the origin of those mutations matters. Most cancers are “sporadic,” meaning the DNA damage happens after birth from things like sun exposure, smoking, aging, or simple copying errors as cells divide. These mutations can’t be passed to children.
Hereditary cancers start with a mutation already present in a parent’s egg or sperm cell. That means the altered gene gets copied into every cell of the child’s body from the moment of conception. The person doesn’t inherit cancer itself, but they inherit a broken safety mechanism, one that would normally help repair DNA damage or stop cells from growing out of control. With one layer of protection already missing, it takes fewer additional hits for a cell to turn cancerous. This is why hereditary cancers tend to appear at younger ages and sometimes affect multiple organs.
Breast, Ovarian, and Prostate Cancer
The BRCA1 and BRCA2 genes are the most widely known hereditary cancer genes. They normally produce proteins that repair damaged DNA. When either gene carries a harmful mutation, that repair system falters.
More than 60% of women who inherit a BRCA1 or BRCA2 mutation will develop breast cancer in their lifetime, compared to about 13% of women in the general population. Ovarian cancer risk is also sharply elevated: 39% to 58% for BRCA1 carriers and 13% to 29% for BRCA2 carriers. Men are affected too. BRCA2 mutations raise prostate cancer risk significantly, with 19% to 61% of male carriers developing prostate cancer by age 80. BRCA2 also increases pancreatic cancer risk by 3.5 to 10 times above average.
These mutations are more common in people of Ashkenazi Jewish descent, though they occur across all ethnic groups. Preventive surgery for BRCA carriers, including removal of breast tissue or the ovaries and fallopian tubes, reduces cancer risk by roughly 95%. These are major decisions typically made with genetic counselors after confirmed testing.
Colorectal and Uterine Cancer
Lynch syndrome is the most common hereditary cause of colorectal cancer, responsible for about 3,800 colorectal cancers and 1,600 uterine cancers each year in the United States. It’s caused by mutations in genes that normally fix small errors when DNA copies itself. When those repair genes don’t work properly, mistakes pile up faster than usual.
People with Lynch syndrome are more likely to develop cancer before age 50. The list of associated cancers extends well beyond the colon and uterus to include ovarian, stomach, small intestine, urinary tract (kidney, ureter, bladder), pancreatic, prostate, brain, and certain skin cancers. Because the cancer risk spans so many organs, people with Lynch syndrome typically follow aggressive screening schedules starting in their 20s or 30s, including colonoscopies every one to two years.
A separate inherited condition called familial adenomatous polyposis, caused by mutations in the APC gene, leads to hundreds or thousands of polyps forming in the colon during adolescence or early adulthood. Without intervention, colorectal cancer is nearly inevitable.
Pancreatic Cancer
Pancreatic cancer has one of the strongest hereditary components of any cancer. Several genes contribute to inherited risk, including BRCA2, PALB2, ATM, and CDKN2A. Lynch syndrome genes also raise pancreatic cancer risk. People with Peutz-Jeghers syndrome, a rare condition caused by mutations in the STK11 gene, face elevated pancreatic risk along with increased risk for breast, colon, and stomach cancers.
Hereditary pancreatitis, caused by mutations in genes like PRSS1, creates chronic inflammation in the pancreas that substantially increases cancer risk over decades. Because pancreatic cancer is difficult to detect early and has a poor prognosis, identifying people with inherited risk is especially valuable for early screening.
Li-Fraumeni Syndrome: A Wide Spectrum
Li-Fraumeni syndrome stands out because it doesn’t target one or two organs. It’s caused by mutations in TP53, a gene sometimes called “the guardian of the genome” because its protein monitors cells for DNA damage and triggers repair or self-destruction when something goes wrong. When TP53 is broken from birth, cancers can appear almost anywhere in the body.
Five cancer types account for most Li-Fraumeni tumors: breast cancer (often diagnosed very young), brain tumors, bone cancers, soft-tissue sarcomas, and adrenal gland cancers. But the syndrome is also linked to leukemia, colorectal cancer, stomach cancer, lung cancer, melanoma, and prostate cancer. Children with this mutation can develop cancers as early as infancy, and affected adults often face multiple primary cancers over their lifetime.
Other Hereditary Cancer Syndromes
Several less common but well-defined syndromes also carry significant cancer risk:
- Hereditary diffuse gastric cancer is caused by CDH1 gene mutations and raises the risk of a particularly aggressive form of stomach cancer, as well as lobular breast cancer.
- PTEN hamartoma tumor syndrome increases risk for cancers of the breast, thyroid, uterus, kidney, colon, and skin.
- Multiple endocrine neoplasia (MEN) syndromes affect hormone-producing glands. MEN2, caused by RET gene mutations, is strongly linked to medullary thyroid cancer.
- Gorlin syndrome leads to numerous basal cell skin cancers, sometimes beginning in childhood, and carries a risk of certain brain tumors.
Signs Your Cancer Could Be Hereditary
Certain patterns in a family’s cancer history suggest a genetic cause rather than bad luck. The CDC highlights several red flags worth discussing with a doctor: a relative diagnosed with breast, uterine, or colorectal cancer before age 50; two or more relatives on the same side of the family with the same or related cancers; any female relative with ovarian cancer; any male relative with breast cancer; or Ashkenazi Jewish ancestry.
Other clues include a single person developing multiple separate cancers, cancer appearing in a paired organ (both breasts, both kidneys), or rare cancers like adrenal tumors showing up in a family. The more of these features present, the stronger the case for genetic testing.
What Genetic Testing Involves
Genetic testing for hereditary cancer typically uses a blood or saliva sample to look for mutations in known cancer-predisposition genes. Modern multigene panel tests can screen dozens of genes at once rather than testing one at a time. Current guidelines recommend BRCA1/2 testing for all newly diagnosed breast cancer patients age 65 or younger, and selectively for older patients based on family history or treatment decisions.
A positive result doesn’t mean cancer is certain. It means your risk is elevated, sometimes dramatically, and it opens the door to more intensive screening, preventive medications, or risk-reducing surgery. A negative result in someone with a strong family history doesn’t fully rule out hereditary risk either, since not all cancer genes have been identified yet. Genetic counselors help interpret results and guide next steps, both for the person tested and for their blood relatives who may carry the same mutation.